Evidence map›Paper›PMID 25045454›Full record

ArticleMediterranean journal of hematology and infectious diseases2014

Cost of hematopoietic stem cell transplantation in India.

Sanjeev Kumar Sharma, Dharma Choudhary, Nitin Gupta, Mayank Dhamija, Vipin Khandelwal, Gaurav Kharya, Anil Handoo, Rasika Setia, Arpita Arora

Abstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Cost of HSCT in a Tertiary Care Public Sector Hospital in India.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Autologous Stem Cell Transplantation for Multiple Myeloma: Single Centre Experience from North India.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2018
    Article
  14. Review
  15. Cost of Treatment of Multiple Myeloma in a Public Sector Tertiary Care Hospital of North India.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2018
    Article
  16. Article
  17. Article
  18. Review
  19. Hematopoietic Stem Cell Transplant in Elderly Patients: Experience from a Tertiary Care Centre in Northern India.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sanjeev Kumar SharmaDepartment of Hemato-oncology and Bone marrow transplantation. BLK Superspeciality Hospital, Pusa Road, New Delhi, India.
Dharma ChoudharyDepartment of Hemato-oncology and Bone marrow transplantation. BLK Superspeciality Hospital, Pusa Road, New Delhi, India.
Nitin GuptaDepartment of Hemato-oncology and Bone marrow transplantation. BLK Superspeciality Hospital, Pusa Road, New Delhi, India.
Mayank DhamijaDepartment of Hemato-oncology and Bone marrow transplantation. BLK Superspeciality Hospital, Pusa Road, New Delhi, India.
Vipin KhandelwalDepartment of Hemato-oncology and Bone marrow transplantation. BLK Superspeciality Hospital, Pusa Road, New Delhi, India.
Gaurav KharyaDepartment of Hemato-oncology and Bone marrow transplantation. BLK Superspeciality Hospital, Pusa Road, New Delhi, India.
Anil HandooDepartment of Hemato-oncology and Bone marrow transplantation. BLK Superspeciality Hospital, Pusa Road, New Delhi, India.
Rasika SetiaDepartment of Hemato-oncology and Bone marrow transplantation. BLK Superspeciality Hospital, Pusa Road, New Delhi, India.
Arpita AroraDepartment of Hemato-oncology and Bone marrow transplantation. BLK Superspeciality Hospital, Pusa Road, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic stem cell transplantation (HSCT) is a definite cure for many hematological diseases. With the increasing indications for HSCT and its relatively low cost in Indian subcontinent, an increasing number of patients are opting for this procedure. We retrospectively analyzed the cost of one hundred sixty two HSCTs done at our center in the last three years. The median cost of autologous transplant was USD, $ 12,500 (range $ 10,331-39,367) and the median cost of allogeneic transplant was $ 17,914 (range $ 10,832-44,701). The cost of HSCT is cheaper here compared to that in developed countries and success rates are nearly equivalent. The major factors contributing to the cost are related to the complications post-transplant mainly infections and graft versus host disease, which are also the reasons for the increased stay in the hospital.

Identifiers

PMID25045454
PMCPMC4103507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.